Predpokladaný rast EPS Q/Q spoločnosti Cellectis
Aká je hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Cellectis?
Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Cellectis je -45.12%
Aká je definícia metriky Predpokladaný rast EPS Q/Q?
Očakávaný rast EPS (Estimated quarterly EPS growth rate) z roka na rok je predpokladaný rast EPS spoločnosti za ďaľší kvartál v porovnaní s výsledkami z minulého kvartálu.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Predpokladaný rast EPS Q/Q spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Cellectis
Čomu sa venuje spoločnosť Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Firmy s metrikou predpokladaný rast eps q/q podobnou spoločnosti Cellectis
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Banco Macro S.A je -45.38%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti American International Inc je -45.36%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Western Union je -45.31%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Passage Bio Inc je -45.26%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Teradyne je -45.26%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Avanti Feeds je -45.24%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Cellectis je -45.12%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Companhia Siderurgica Nacional je -45.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Copperleaf Technologies je -45.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Unity Biotechnology Inc je -45.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Nano Dimension Ltd je -45.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti PLx Pharma je -45.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti BXP je -44.92%